Masimo | MASI - Ebit

Stock Price
178.47
Daily Change
0.12 0.07%
Monthly
0.10%
Yearly
14.68%
Q2 Forecast
174.62

Masimo reported $77.4M in EBIT for its fiscal quarter ending in March of 2026.





Ebit Change Date
Abbott USD 1.85B 684M Mar/2026
Accuray USD 11.38M 12.71M Sep/2024
Align Technology USD 178.05M 46.66M Mar/2026
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 526K 1.96M Mar/2026
Avanos Medical USD 8.9M 15.87M Mar/2026
Baxter International USD 66M 280.2M Mar/2026
Becton, Dickinson and Co. USD 627M 36M Mar/2026
Boston Scientific USD 1.05B 190M Mar/2026
Dexcom USD 255.3M 67.7M Mar/2026
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
General Electric Aerospace USD 2.09B 416M Mar/2026
Globus Medical USD 164M 17.31M Mar/2026
Haemonetics USD 67.4M 13.71M Dec/2025
Insulet USD 122M 24.3M Mar/2026
Integra LifeSciences USD 11.47M 54.54M Mar/2026
Intuitive Surgical USD 859.7M 5.6M Mar/2026
Masimo USD 77.4M 6.5M Mar/2026
Medtronic USD 1.74B 40M Dec/2025
Orthofix International USD 6.12M 1.91M Dec/2025
Owens Minor USD 814K 28.08M Dec/2025
ResMed USD 505.67M 8.07M Mar/2026
Steris USD 318.7M 40.7M Mar/2026
Stryker USD 1.1B 867M Mar/2026
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 37.03M 686K Mar/2026
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Zimmer Biomet Holdings USD 395.1M 92.2M Mar/2026